Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.

Show other versions (1)

Bibliographic Details
Main Authors:	Kotsianidis, I, Silk, J, Patterson, S, Almeida, A, Tsatalas, C, Bourikas, G, Cerundolo, V, Roberts, I, Karadimitris, A
Format:	Conference item
Published:	2005

Similar Items

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
by: Kotsianidis, I, et al.
Published: (2006)

Human invariant NKT cells are required for effective in vitro alloresponses.
by: Patterson, S, et al.
Published: (2005)

Activated invariant NKT cells regulate osteoclast development and function.
by: Hu, M, et al.
Published: (2011)

Harnessing invariant NKT cells in vaccination strategies.
by: Cerundolo, V, et al.
Published: (2009)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors
by: Patterson, S, et al.
Published: (2008)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
by: Patterson, S, et al.
Published: (2008)

Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1D interaction and killer immunoglobulin receptors
by: Patterson, S, et al.
Published: (2008)

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
by: Reddy, BG, et al.
Published: (2009)

The role of invariant NKT cells at the interface of innate and adaptive immunity
by: Cerundolo, V
Published: (2010)

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation
by: Hu, M, et al.
Published: (2008)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
by: Salio, M, et al.
Published: (2011)

The role of invariant NKT cells at the interface of innate and adaptive immunity.
by: Cerundolo, V, et al.
Published: (2010)

Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2.
by: Lawson, V, et al.
Published: (2009)

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
by: Hermans, I, et al.
Published: (2007)

Harnessing invariant NKT-cells to enhance antigen specific immune responses
by: Cerundolo, V
Published: (2014)

The role of invariant NKT cells in enhancing antigen specific T and B cell responses
by: Cerundolo, V
Published: (2005)

Essential role for autophagy during invariant NKT cell development
by: Salio, M, et al.
Published: (2014)

Description of invariant NKT cells.
by: Katarzyna Karwicka, et al.
Published: (2021-09-01)

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
by: Anastasios Karadimitris, et al.
Published: (2019-06-01)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
by: Felix Scheuplein, et al.
Published: (2015-01-01)

Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells
by: Silk, J, et al.
Published: (2008)

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
by: Hermans, I, et al.
Published: (2004)

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
by: Silk, J, et al.
Published: (2008)

Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.
by: Mussai, F, et al.
Published: (2012)

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
by: Hermans, I, et al.
Published: (2003)

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
by: Porubsky, S, et al.
Published: (2012)

NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer
by: Somayeh Rezaeifard, et al.
Published: (2019-12-01)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
by: Benjamin J. Wolf, et al.
Published: (2018-03-01)

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
by: Amanda C Stanley, et al.
Published: (2008-02-01)

Harnessing NKT cells for therapeutic applications.
by: Cerundolo, V, et al.
Published: (2007)

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.
by: De Santo, C, et al.
Published: (2010)

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.
by: Barral, P, et al.
Published: (2008)

A humanized monoclonal antibody specific for invariant Natural Killer T (iNKT) cells for in vivo depletion.
by: Felix Scheuplein, et al.
Published: (2013-01-01)

Invariant NKT cell response to dengue virus infection in human.
by: Ponpan Matangkasombut, et al.
Published: (2014-06-01)

Characterization and Functional Analysis of Mouse Invariant Natural T (iNKT) Cells
by: Bezbradica, J, et al.
Published: (2006)

The actin cytoskeleton modulates the activation of invariant NKT cells by segregating CD1d nanoclusters on antigen presenting cells
by: Cerundolo, V, et al.
Published: (2016)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
by: Shin-ichiro Fujii, et al.
Published: (2018-06-01)

Human CD4- invariant NKT lymphocytes regulate graft versus host disease
by: Tereza Coman, et al.
Published: (2018-11-01)

The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection
by: McEwen-Smith, R, et al.
Published: (2013)

The complement system and invariant natural killer T (iNKT) cell responses
by: Malik, N
Published: (2021)